72 Investment Holdings’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

72 Investment Holdings’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-352,941	Closed	-$263K	–	7
2024 Q4	$263K	Hold	352,941	–	–	0.54%	7
2024 Q3	$431K	Hold	352,941	–	–	0.93%	6
2024 Q2	$731K	Hold	352,941	–	–	1.84%	7
2024 Q1	$1.29M	Hold	352,941	–	–	1.92%	7
2023 Q4	$1.06M	Hold	352,941	–	–	4.72%	6
2023 Q3	$759K	Hold	352,941	–	–	5.08%	5
2023 Q2	$1.98M	Hold	352,941	–	–	15.4%	3
2023 Q1	$2.13M	Hold	352,941	–	–	1.01%	4
2022 Q4	$2.02M	Hold	352,941	–	–	0.93%	5
2022 Q3	$1.91M	Hold	352,941	–	–	1.52%	5
2022 Q2	$1.34M	Hold	352,941	–	–	2.07%	5
2022 Q1	$2.2M	Hold	352,941	–	–	2.41%	5
2021 Q4	$4M	Hold	352,941	–	–	3.55%	5
2021 Q3	$6.65M	Buy	+352,941	New	+$6.77M	8.31%	4

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

72 Investment Holdings's OMGA Position: Q1 2025 in Review

72 Investment Holdings sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 352,941 shares — an estimated $263K sold.

72 Investment Holdings first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $6.65M in Q3 2021. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

72 Investment Holdings reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
72 Investment Holdings sold 352,941 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $263K.
72 Investment Holdings first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
72 Investment Holdings's Omega Therapeutics, Inc. Common Stock position peaked at $6.65M in Q3 2021.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on 72 Investment Holdings's 13F filing for Q1 2025, filed 15 May 2025.